Speaker illustration

Professor Nabil Dib

Mercy Gilbert Medical Center, Phoenix (United States of America)

Member of:

European Society of Cardiology

Nabil Dib, M.D., MSc, FACC, FESC Professor of Medicine, Cardiology Founder and President, International Society for Cardiovascular Translational Research (ISCTR) Founder and Editor in Chief of the Journal of Cardiovascular Translational Research. (JCTR) Director, Clinical and Translational Research at Dignity Health He completed his Interventional Cardiology Fellowship Program at Harvard Medical School, Beth-Israel-Deaconess Medical Center in Boston. Dr. Dib also completed an additional year in Investigational Devices at Harvard Medical School. Additionally, he continued his education at Harvard School of Public Health, where he obtained a degree in Master of Science in Epidemiology, concentrated on a clinical trial design and clinical effectiveness. He has participated in over 100 clinical trials and developed his own catheters for the delivery of therapeutics and has edited 2 books on Cardiovascular Translational Research.

Challenges and opportunities for clinical investigation in the future

Event: ESC Congress 2018

Topic: Research Methodology

Session type: Symposium

Thumbnail

Key steps to innovation in medical devices

Event: ESC Congress 2018

Topic: Public Health and Health Economics

Session type: Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk